Guillain-Barré syndrome and H1N1 influenza vaccine in UK children

The Lancet

Volumn 378, Issue 9802, 2011, Pages 1545-1546

  Verity, Christopher ^a   Stellitano, Lesley ^a   Winstone, Anne Marie ^a   Andrews, Nick ^b   Stowe, Julia ^b   Miller, Elizabeth ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; INFLUENZA VACCINATION; LETTER; PANDEMIC INFLUENZA; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SEASONAL INFLUENZA; UNITED KINGDOM; VIRION;

EID: 80155132370     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61665-6     Document Type: Letter

References (5)

1. LB Schonberger, DJ Bregman, JZ Sullivan-Bolyai et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977 Am J Epidemiol 110 1979 105
2. M Sethi, R Pebody Pandemic H1N1 (swine) influenza vaccine uptake amongst patient groups in primary care in England 2009/2010 http://www.dh.gov.uk/prod- consum-dh/groups/dh-digitalassets/@dh/@en/@ps/documents/digitalasset/dh-121014. pdf (accessed May 16, 2011).
3. S Black, J Eskola, CA Siegrist et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines Lancet 374 2009 2115 2122
4. J Stowe, N Andrews, L Wise, E Miller Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database Am J Epidemiol 169 2009 382 388
5. N Andrews, P Waight, CF Yung, E Miller Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England J Infect Dis 203 2011 32 39